These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18071898)

  • 41. The Impact of Technical Assistance and Implementation Support on Program Capacity to Deliver Integrated Services.
    Chaple M; Sacks S
    J Behav Health Serv Res; 2016 Jan; 43(1):3-17. PubMed ID: 24928534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mental health provider perspectives on co-occurring substance use among severely mentally ill clients.
    Mericle AA; Alvidrez J; Havassy BE
    J Psychoactive Drugs; 2007 Jun; 39(2):173-81. PubMed ID: 17703712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A county survey of mental health services in drug treatment programs.
    Grella CE; Hser YI
    Psychiatr Serv; 1997 Jul; 48(7):950-2. PubMed ID: 9219307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of dually diagnosed clients.
    Little J
    J Psychoactive Drugs; 2001; 33(1):27-31. PubMed ID: 11332998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrating mental health and addictions services to improve client outcomes.
    Peterson AL
    Issues Ment Health Nurs; 2013 Oct; 34(10):752-6. PubMed ID: 24066651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Racial distribution of dual-diagnosis clients in public sector mental health and drug treatment settings.
    Alvidrez J; Havassy BE
    J Health Care Poor Underserved; 2005 Feb; 16(1):53-62. PubMed ID: 15741709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual diagnosis patients in substance abuse treatment: relationship of general coping and substance-specific coping to 1-year outcomes.
    Moggi F; Ouimette PC; Moos RH; Finney JW
    Addiction; 1999 Dec; 94(12):1805-16. PubMed ID: 10717959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The client with substance abuse/mental illness: mandate for collaboration.
    Clement JA; Williams EB; Waters C
    Arch Psychiatr Nurs; 1993 Aug; 7(4):189-96. PubMed ID: 8239721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancing services for offenders: the impact on treatment completion.
    Arnold EM; Stewart JC; McNeece CA
    J Psychoactive Drugs; 2001; 33(3):255-62. PubMed ID: 11718318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Counselor training in several evidence-based psychosocial addiction treatments in private US substance abuse treatment centers.
    Olmstead TA; Abraham AJ; Martino S; Roman PM
    Drug Alcohol Depend; 2012 Jan; 120(1-3):149-54. PubMed ID: 21831536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review of integrated mental health and substance abuse treatment for patients with dual disorders.
    Drake RE; Mercer-McFadden C; Mueser KT; McHugo GJ; Bond GR
    Schizophr Bull; 1998; 24(4):589-608. PubMed ID: 9853791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia.
    Kingston REF; Marel C; Mills KL
    Drug Alcohol Rev; 2017 Jul; 36(4):527-539. PubMed ID: 27786426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Severely mentally ill patients with and without substance use disorders: characteristics associated with treatment attrition.
    Primm AB; Gomez MB; Tzolova-Iontchev I; Perry W; Vu HT; Crum RM
    Community Ment Health J; 2000 Jun; 36(3):235-46. PubMed ID: 10933241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mental health versus substance abuse treatment programs for dually diagnosed patients.
    Primm AB; Gomez MB; Tzolova-Iontchev I; Perry W; Vu HT; Crum RM
    J Subst Abuse Treat; 2000 Oct; 19(3):285-90. PubMed ID: 11027899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual diagnosis clients' treatment satisfaction - a systematic review.
    Schulte SJ; Meier PS; Stirling J
    BMC Psychiatry; 2011 Apr; 11():64. PubMed ID: 21501510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Relationship Between Client Characteristics and Wraparound Services in Substance Use Disorder Treatment Centers.
    Paino M; Aletraris L; Roman P
    J Stud Alcohol Drugs; 2016 Jan; 77(1):160-9. PubMed ID: 26751366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The STIRR model of best practices for blood-borne diseases among clients with serious mental illness.
    Rosenberg S; Brunette M; Oxman T; Marsh B; Dietrich A; Mueser K; Drake R; Torrey W; Vidaver R
    Psychiatr Serv; 2004 Jun; 55(6):660-4. PubMed ID: 15175463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of diversion on adults with co-occurring mental illness and substance use: outcomes from a national multi-site study.
    Broner N; Lattimore PK; Cowell AJ; Schlenger WE
    Behav Sci Law; 2004; 22(4):519-41. PubMed ID: 15282838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.